The Office of New Drugs at the FDA is in the middle of a major, phased reorganization at the moment. All divisions are impacted, including Neurology, which will be split in two, and Psychiatry.
As part of the reorganization, starting this month, a new Office of Rare Diseases, Paediatrics, Urological & Reproductive Medicine will be formed. In addition, there will be new divisions created for Pharm/Tox for Neuroscience and Pharm/Tox for Rare Diseases, Paediatrics, Urological & Reproductive Medicine.
https://www.fda.gov/drugs/regulator...nges-office-translational-sciences-and-office
The Office of New Drugs at the FDA is in the middle of a major,...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$14.28 |
Change
0.080(0.56%) |
Mkt cap ! $1.777B | |||
| Open | High | Low | Value | Volume |
| $14.22 | $14.55 | $14.10 | $4.611M | 320.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 6352 | $14.28 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.38 | 4000 | 1 |
View Market Depth
| Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
| NEU (ASX) Chart |